Integrated Graphene, the Scottish technology integration company which has pioneered a high performing, low cost, 3D Graphene Foam electrode, Gii-Sens®, for biosensing, has partnered with a world-leading team of scientists to develop a point-of-care biomedical test to revolutionise the safety of liver transplants.
A pioneering project, which aims to develop advanced sensors for use in robotic systems, could transform prosthetics and robotic limbs.
Integrated Graphene, a Scotland-based technology development and integration company, has announced plans to invest up to £8 million in scaling up its revolutionary 3D Graphene foam, Gii®, manufacturing process to meet surging global demand from the human diagnostics and energy markets.
